ATLAS: Risk-adapted Triplet Maintenance with Carfilzomib, Lenalidomide and Dexamethasone – Still Shrugging?. Issue 2 (2022)

Record Type:: Journal Article
Title:: ATLAS: Risk-adapted Triplet Maintenance with Carfilzomib, Lenalidomide and Dexamethasone – Still Shrugging?. Issue 2 (2022)
Main Title:: ATLAS: Risk-adapted Triplet Maintenance with Carfilzomib, Lenalidomide and Dexamethasone – Still Shrugging?
Authors:: Franz, Joseph
Lonia, Sagar
Is Part Of:: Touch reviews in oncology & haematology. Volume 18:Issue 2(2022)
Journal:: Touch reviews in oncology & haematology
Issue:: Volume 18:Issue 2(2022)
Issue Display:: Volume 18, Issue 2 (2022)
Year:: 2022
Volume:: 18
Issue:: 2
Issue Sort Value:: 2022-0018-0002-0000
Page Start:: 96
Page End:
Publication Date:: 2022
Subjects:: Oncology -- Periodicals
Hematology -- Periodicals
616.994005
Journal URLs:: https://touchoncology.com/journals/oncology-hematology-review-us/touchreviews-in-oncology-haematology-volume-17-issue-1-2021/ ↗
Languages:: English
ISSNs:: 2752-5481
Deposit Type:: Legaldeposit
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗
Physical Locations:: British Library HMNTS - ELD Digital store
Ingest File:: 26266.xml